Navigation Links
Laureate Pharma Elects New Board Member
Date:8/18/2009

PRINCETON, N.J., Aug. 18 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced the Election of Joel A. Tune as a new member of its Board of Directors.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080131/NETH020LOGO )

Along with providing expert guidance and strategic direction focused on Laureate's contract manufacturing business, Mr. Tune brings to Laureate more than 20 years of experience in P&L, strategy, operations, marketing and engineering leadership, in rapid-growth and transitional health products and service businesses. Throughout his career, he has worked in general management, sales and marketing, strategy, business development and engineering.

"Joel's exceptional mix of contract manufacturing expertise, in-depth knowledge of customer needs, and strong leadership skills will enable us to propel Laureate's growth and development and to achieve worldwide recognition for our fully-integrated contract development and bioprocessing services," said Robert J. Broeze, Ph.D., President & Chief Executive Officer of Laureate." As we continue to enhance the value proposition for our customers and to continue to build upon our momentum, we look to our new partnership with Joel to help aid in achieving our objectives for 2009 and beyond."

Mr. Tune most recently served as Vice President / General Manager, Global Drug Delivery of Baxter International where he transformed an established business, doubling revenues over five years to reach $800M+. Mr. Tune realigned the business model, products and market focus toward high value, rapidly expanding outsourcing services and technologies. He also successfully led a 14-member leadership team; 200 business development, sales and marketing, and product development professionals; over 800 employees in a dedicated facility; and effectively directed shared services production operations with 13 global manufacturing facilities. He concurrently, served on Baxter's senior management team with active involvement in cross-business communications, investor relations and industry outreach awareness. Previously, he was Vice President, Strategy & Business Development for Baxter and was responsible for in-house strategy and venture development. He orchestrated cross-divisional initiatives to create value within Baxter's largest product and distribution operations.

About Laureate Pharma

Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, New Jersey. Laureate Pharma offers superior bioprocessing services that accelerate new products from development through production. Laureate provides a wide range of specialized services from process design and development to full-scale cGMP production, purification, aseptic filling, testing, validation, analytical services, and regulatory support. Laureate is focused on two active segments of the biopharmaceutical industry: monoclonal antibodies and recombinant protein products. For more information, contact Robert J. Broeze, Ph.D., President & CEO at (609) 919-3400, or info@laureatepharma.com or visit www.laureatepharma.com.

Available Topic Experts: For information on the listed experts, click appropriate link.

Robert Broeze

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=84360


'/>"/>
SOURCE Laureate Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development
2. Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010
3. US Oncology Named 2009 Laureate by IDG Computerworld Honors Program
4. Nobel Laureates to Speak at Keystone Symposia RNA Silencing Conference
5. Laureate Pharma Honored as Emerging Life Sciences Company of the Year
6. Laureate Pharma Announces Agreement with Tolera Therapeutics, Inc.
7. Laureate Announces Manufacturing Agreement with Tolerx
8. Laureate Pharma to Add More Manufacturing Capacity
9. ARUP Laboratories ARUP Consult(R) Recognized as a Computerworld Honors Program Laureate
10. Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC
11. Laureate Pharma Reports Record Growth for 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... ... August 15, 2017 , ... ... accelerate pharmaceutical and biotherapeutics development, announces the launch of the new NHS ... to gain kinetic binding data for a wide range of molecules, including small ...
(Date:8/15/2017)... (PRWEB) , ... August 15, 2017 , ... The ... time on Immuno-Oncology 360° (IO360°) programming through a series of upcoming panels and events. ... February 7-9, 2018, at The Roosevelt Hotel in New York City. , “With our ...
(Date:8/14/2017)... Portland, Oregon (PRWEB) , ... August 14, 2017 ... ... modules that provide essential device-to-computer interconnect using USB or PCI Express, announced the ... hardware. , SYZYGY is intended to satisfy the need for a compact, low ...
(Date:8/11/2017)... ... ... Algenist continues to disrupt the skincare industry with today’s debut of GENIUS Liquid ... the key structural element skin needs to maintain its youthful appearance and Algenist is ... First to market with proprietary collagen water active , Active ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
(Date:3/30/2017)... 2017 Trends, opportunities and forecast in this ... technology (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, ... end use industry (government and law enforcement, commercial and ... and others), and by region ( North America ... Asia Pacific , and the Rest of the ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access ... 15.1% over the next decade to reach approximately $1,580 million by ... and forecasts for all the given segments on global as well ...
Breaking Biology News(10 mins):